Notice of Q1 Results

RNS Number : 8935P
Benchmark Holdings PLC
14 February 2023
 

14 February 2023

 

Benchmark Holdings plc

 

("Benchmark", the "Company" or the "Group")

 

Notice of Q1 Results

 

Presentation for analysts and institutional investors

 

Benchmark Holdings plc (AIM: BMK, Euronext Growth Oslo: BMK), the aquaculture biotechnology business, will announce its Q1 results, for the three month period ended 31 December 2022, on Tuesday 28 February 2023. 

 

Presentation for analysts and investors at 9 am CET

 

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host an in-person presentation for analysts and institutional investors on the day at 9.00 am CET/8.00 am UK time in Oslo, Norway. The presentation will take place at Hotel Continental, Stortingsgata 24/26, 0117 Oslo.

 

A live webcast of the presentation is available for analysts and investors to join remotely at the following link: https://channel.royalcast.com/hegnarmedia/#!/hegnarmedia/20230228_7  

 

For further details, and to register your interest, please contact  benchmark@mhpgroup.com .

 

Equity Development webcast on Wednesday 1 March at 12 pm UK time

 

Trond Williksen, Chief Executive Officer and Septima Maguire, Chief Financial Officer will host a second webcast for retail investors and wealth managers on Wednesday 1 March at 13.00 pm CET/12.00 pm UK time. The webcast is open to all existing and potential shareholders.

 

To register please visit: https://www.equitydevelopment.co.uk/news-and-events/benchmark-q1results-presentation-1march2023

 

A recording of the presentation will be available after the event on the Equity Development website .

 

 

  Enquiries

For further information, please contact:


Benchmark Holdings plc

Tel:  0114 240 9939

Trond Williksen, CEO


Septima Maguire, CFO


Ivonne Cantu, Investor Relations




Numis (Broker and NOMAD)

Tel:  020 7260 1000

James Black, Freddie Barnfield, Duncan Monteith




MHP

Tel:  020 3128 8004

Katie Hunt, Reg Hoare, Veronica Farah

benchmark@mhpgroup.com

 

Equity Development

Hannah Crowe

 

Tel:  020 7065 2692


 

 

About Benchmark

Benchmark is a leading aquaculture biotechnology company. Benchmark's mission is to enable aquaculture producers to improve their sustainability and profitability.

We bring together biology and technology to develop innovative products and solutions which improve yield, quality and animal health and welfare for our customers. We do this by improving the genetic make-up, health and nutrition of their stock - from broodstock and hatchery through to nursery and grow out.

Benchmark has a broad portfolio of products and solutions, including salmon eggs, live feed (Artemia), specialist diets and probiotics and sea lice treatments. Find out more at www.benchmarkplc.com .

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORGPUCWPUPWGGC
UK 100

Latest directors dealings